Biogen’s Henshaw Insists Data Is Key In Bolstering Biosimilars

 
• By David Wallace
  
Interface
Biogen’s Ian Henshaw Says Data Can Be As Important As Price In Driving Uptake • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products